Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,238 trials

NCT07819760
Recruiting
Radical Prostatectomy Without Prior Biopsy
Not applicable · Russia · 1 site
Registry update: 20 Oct 2026
NCT07871435
Recruiting
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Phase 1/2 · South Korea, United States · 6 sites
Registry update: 9 Nov 2026
NCT04589468
Recruiting
Researching the Effect of Exercise on Cancer
Not applicable · United States · 9 sites
Registry update: 3 Nov 2026
2025-524080-20-00
Recruiting
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
Phase 1 · Germany, Spain, France, Italy · 6 sites
Registry update: 23 Oct 2026
NCT07910019
Recruiting
Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers
Not applicable · United States · 1 site
Registry update: 2 Nov 2026
NCT07386496
Recruiting
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Not applicable · Hong Kong · 1 site
Registry update: 27 Oct 2026
NCT07568236
Recruiting
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Phase 2 · Hong Kong · 1 site
Registry update: 7 Oct 2026
NCT07879820
Recruiting
PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer
Not applicable · Italy · 1 site
Registry update: 19 Oct 2026
NCT06615752
Recruiting
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Phase 1/2 · United States · 1 site
Registry update: 15 Apr 2026
NCT07729150
Recruiting
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
Not applicable · United States · 1 site
Registry update: 25 Sept 2026
NCT07697989
Recruiting
Pluvicto Real-world Investigation in Survival in Metastatic CRPC
Not applicable · United States · 1 site
Registry update: 30 Oct 2026
NCT07686380
Recruiting
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Phase 2 · United States · 1 site
Registry update: 6 Oct 2026
NCT07484269
Recruiting
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Not applicable · Switzerland · 1 site
Registry update: 30 Oct 2026
NCT07831824
Recruiting
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
Phase 2/3 · United States · 1 site
Registry update: 21 Sept 2026
NCT07875192
Recruiting
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
Not applicable · United States · 1 site
Registry update: 15 Oct 2026
NCT07783282
Recruiting
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer
Phase 1 · Bulgaria · 1 site
Registry update: 16 Oct 2026
NCT07897071
Recruiting
AXT-1003 Combination With Enzalutamide in Participants With mCRPC
Phase 1 · China · 4 sites
Registry update: 27 Oct 2026
NCT07860047
Recruiting
Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer
Phase 2 · Germany · 4 sites
Registry update: 6 Oct 2026
NCT07871110
Recruiting
Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 2 · China · 16 sites
Registry update: 13 Oct 2026
NCT07832292
Recruiting
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
Phase 2 · Australia, China, Japan, United States · 14 sites
Registry update: 3 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.